Search all trials

Find therapies in clinical trials near you – page 16

Search by disease and location to discover available clinical trials matching your criteria. Updated every day from authoritative EU registries.

recruiting: 3 962
countries: 28
conditions: 2 101

3 962 trials recruiting28 European countries2 101 conditions coveredUpdated today

Quick filters

Breast cancer metastatic

Recruiting

InvestigationalNo placebo

Study on Lasofoxifene, Fulvestrant, and Abemaciclib for Advanced Breast Cancer in Women and Men with ESR1 Mutation

InvestigationalNo placebo

France

Participants:18–64 years · 65+ years
Substances:Abemaciclib

Contact Research Centre

Type IIa hyperlipidaemia

Recruiting

Registered drugNo placebo

Study on Long-Term Safety of Inclisiran for Patients with Familial Hypercholesterolemia Who Completed Previous Adolescent Studies

Registered drugNo placebo

France

Participants:0–17 years · 18–64 years
Substances:Inclisiran

Contact Research Centre

Endometrial cancer

Recruiting

Registered drugNo placebo

Study on Olaparib for Patients with p53abn Endometrial Cancer After Chemoradiation Therapy

Registered drugNo placebo

France

Participants:18–64 years · 65+ years
Substances:Olaparib

Contact Research Centre

Chronic cutaneous lupus erythematosus+2

Recruiting

InvestigationalNo placebo

Study on Long-Term Safety and Efficacy of Litifilimab for Adults with Active Subacute or Chronic Cutaneous Lupus Erythematosus Resistant to Antimalarial Therapy

InvestigationalNo placebo

France

Participants:18–64 years · 65+ years
Substances:Litifilimab

Contact Research Centre

Biliary neoplasm

Recruiting

Registered drugNo placebo

Study on Maintenance Therapy with Cisplatin, Durvalumab, and Trastuzumab for Patients with Advanced Biliary Cancer

Registered drugNo placebo

France

Participants:18–64 years · 65+ years
Substances:Binimetinib

Contact Research Centre

Transitional cell cancer of the renal pelvis and ureter

Recruiting

Registered drugNo placebo

Study of Sacituzumab Govitecan for Patients with Advanced or Metastatic Bladder Cancer

Registered drugNo placebo

France

Participants:18–64 years · 65+ years
Substances:Avelumab

Contact Research Centre

Acute myeloid leukaemia

Recruiting

Registered drugNo placebo

Study Comparing CPX-351 and Chemotherapy for Patients with New Intermediate or High-Risk Acute Myeloid Leukemia

Registered drugNo placebo

France

Participants:18–64 years · 65+ years
Substances:Cytarabine

Contact Research Centre

Hepatocellular carcinoma

Recruiting

Registered drugNo placebo

Study on UCPVax, Atezolizumab, and Bevacizumab for Patients with Unresectable Liver Cancer

Registered drugNo placebo

France

Participants:18–64 years · 65+ years
Substances:Atezolizumab

Contact Research Centre

Behavioural addiction

Recruiting

Registered drug

Study on Nalmefene and Placebo for Reducing Cravings in Patients with Gambling Disorder, Sexual Addiction, or Food Addiction

Registered drug

France

Participants:18–64 years · 65+ years

Contact Research Centre

Interstitial lung disease

Recruiting

Registered drugNo placebo

Study on the Effectiveness and Safety of Rituximab for Patients with Progressive Interstitial Lung Disease with Inflammation

Registered drugNo placebo

France

Participants:18–64 years · 65+ years
Substances:Rituximab

Contact Research Centre

Adrenocortical carcinoma

Recruiting

Registered drugNo placebo

Study on Mitotane Alone or with Cisplatin and Etoposide for Patients with High-Risk Adrenocortical Carcinoma After Surgery

Registered drugNo placebo

France

Participants:18–64 years · 65+ years
Substances:Cisplatin

Contact Research Centre

Acute lymphocytic leukaemia

Recruiting

Registered drugNo placebo

Study on Methotrexate and Dexamethasone for Infants Under One Year with Acute Lymphoblastic Leukemia

Registered drugNo placebo

France

Participants:0–17 years
Substances:Asparaginase

Contact Research Centre

Find therapies in clinical trials near you – page 16

477 trials match your criteria

Breast cancer metastatic

Study on Lasofoxifene, Fulvestrant, and Abemaciclib for Advanced Breast Cancer in Women and Men with ESR1 Mutation

Type IIa hyperlipidaemia

Study on Long-Term Safety of Inclisiran for Patients with Familial Hypercholesterolemia Who Completed Previous Adolescent Studies

Endometrial cancer

Study on Olaparib for Patients with p53abn Endometrial Cancer After Chemoradiation Therapy

Chronic cutaneous lupus erythematosus+2

Study on Long-Term Safety and Efficacy of Litifilimab for Adults with Active Subacute or Chronic Cutaneous Lupus Erythematosus Resistant to Antimalarial Therapy

Biliary neoplasm

Study on Maintenance Therapy with Cisplatin, Durvalumab, and Trastuzumab for Patients with Advanced Biliary Cancer

Transitional cell cancer of the renal pelvis and ureter

Study of Sacituzumab Govitecan for Patients with Advanced or Metastatic Bladder Cancer

Acute myeloid leukaemia

Study Comparing CPX-351 and Chemotherapy for Patients with New Intermediate or High-Risk Acute Myeloid Leukemia

Hepatocellular carcinoma

Study on UCPVax, Atezolizumab, and Bevacizumab for Patients with Unresectable Liver Cancer

Behavioural addiction

Study on Nalmefene and Placebo for Reducing Cravings in Patients with Gambling Disorder, Sexual Addiction, or Food Addiction

Interstitial lung disease

Study on the Effectiveness and Safety of Rituximab for Patients with Progressive Interstitial Lung Disease with Inflammation

Adrenocortical carcinoma

Study on Mitotane Alone or with Cisplatin and Etoposide for Patients with High-Risk Adrenocortical Carcinoma After Surgery

Acute lymphocytic leukaemia

Study on Methotrexate and Dexamethasone for Infants Under One Year with Acute Lymphoblastic Leukemia

Explore other searches

Vaccine trials

Paediatric trials · ages 0–17

Healthy volunteers

Helpful resources

How applying through us works

What happens after you apply

Guides for patients and volunteers

Search filters

Prefer not to search? Our Concierge searches the trials for you.